V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20218978 | 20083466 | null | null | null | 2019-09-05 | 2019-09-06 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100886759 |
| 20218980 | 20083467 | 1.62 | 50 | Neo-adjuvant (N) | null | 2019-06-18 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100898090 |
| 20218981 | 20083468 | null | null | null | 2019-05-07 | 2019-05-07 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 100756707 |
| 20218995 | 20083470 | null | null | null | 2016-06-28 | 2016-07-04 | Cisplatin + Etoposide po&iv 3 day | 02 | null | CISPLATIN + ETOPOSIDE | 100241707 |
| 20219001 | 20083471 | 1.68 | 82 | Palliative (P) | null | 2018-12-09 | null | null | N | CISPLATIN + ETOPOSIDE | 100802652 |
| 20219003 | 20083472 | null | null | null | null | 2016-09-22 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101802201 |
| 20219007 | 20083473 | null | null | null | 2018-11-27 | 2018-12-14 | Cisplatin + Etoposide (3 day) | 02 | null | CISPLATIN + ETOPOSIDE | 101077838 |
| 20219022 | 20083477 | 1.63 | 69 | null | 2017-10-08 | 2017-10-14 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + MITOMYCIN + RT | 101234572 |
| 20219024 | 20083478 | 1.78 | 111.9 | Palliative (P) | 2018-08-23 | 2018-09-08 | CAPECITABINE + IRINOTECAN | 02 | N | CAPECITABINE + IRINOTECAN | 100826680 |
| 20219029 | 20083479 | 1.76 | 45.6 | Palliative (P) | null | 2018-07-02 | null | null | N | HCX | 100562350 |
| 20219030 | 20083480 | 1.8 | 71 | Palliative (P) | 2016-12-05 | 2016-12-18 | null | null | N | HCX | 101397202 |
| 20219033 | 20083481 | 1.77 | 76.5 | Neo-adjuvant (N) | 2017-12-14 | 2017-12-14 | null | null | N | HCX | 101832535 |
| 20219034 | 20083482 | null | 38.9 | Palliative (P) | 2017-04-16 | 2017-04-22 | null | null | null | HCX | 101298717 |
| 20219036 | 20083483 | null | null | null | null | 2018-02-10 | null | null | null | HCX | 100669537 |
| 20219039 | 20083485 | 1.47 | 65 | Palliative (P) | null | 2019-03-26 | null | null | N | LENVATINIB | 100413873 |
| 20219040 | 20083486 | 1.63 | 74.8 | Palliative (P) | null | 2017-09-03 | null | null | N | LENVATINIB | 101387553 |
| 20219050 | 20083487 | 1.65 | 62.3 | Palliative (P) | null | 2018-05-26 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101189055 |
| 20219052 | 20083489 | 1.74 | null | Neo-adjuvant (N) | 2016-04-28 | 2016-04-28 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 100411523 |
| 20219069 | 20083491 | 1.53 | 89.7 | null | 2018-08-15 | 2018-08-15 | CAPECITABINE + MITOMYCIN + RT | N | N | CAPECITABINE + MITOMYCIN + RT | 101554171 |
| 20219072 | 20083493 | 1.71 | 67.5 | Palliative (P) | null | 2019-05-14 | null | null | N | CISPLATIN + ETOPOSIDE | 100153605 |
| 20219075 | 20083494 | null | null | null | null | 2018-09-16 | null | null | null | CAPECITABINE + IRINOTECAN | 101464284 |
| 20219081 | 20083495 | null | null | null | null | 2018-09-15 | null | null | null | HCX | 100398303 |
| 20219088 | 20083498 | null | null | null | null | 2019-11-24 | null | null | null | LENVATINIB | 101126418 |
| 20219090 | 20083499 | 1.45 | 73.9 | Palliative (P) | null | 2019-01-28 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100149596 |
| 20219093 | 20083500 | null | null | null | null | 2019-01-10 | null | null | null | CAPECITABINE + IRINOTECAN | 100746007 |
| 20219101 | 20083503 | 1.64 | 53 | Curative (C) | 2016-05-16 | 2016-05-17 | null | null | N | CISPLATIN + ETOPOSIDE | 100193102 |
| 20219108 | 20083504 | 1.68 | 74.6 | Palliative (P) | 2016-06-05 | 2016-06-12 | CAPECITABINE + CISPLATIN + Trastuzumab | N | N | HCX | 100876273 |
| 20219109 | 20083505 | null | null | null | null | 2018-06-13 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100539243 |
| 20219114 | 20083506 | 1.71 | 87.4 | Neo-adjuvant (N) | 2018-07-28 | 2018-08-02 | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100666992 |
| 20219116 | 20083507 | 1.78 | 88.1 | Palliative (P) | 2018-12-26 | 2018-12-31 | CAPECITABINE + IRINOTECAN | N | N | CAPECITABINE + IRINOTECAN | 101195697 |
| 20219117 | 20083508 | null | null | null | null | 2019-08-10 | null | null | null | LENVATINIB | 101778165 |
| 20219125 | 20083509 | null | null | null | 2017-08-30 | 2017-09-06 | ECarboX | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101837258 |
| 20219126 | 20083510 | 1.8 | 73.5 | Curative (C) | 2019-04-28 | 2019-04-28 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100911524 |
| 20219129 | 20083511 | 1.57 | 65 | Palliative (P) | null | 2018-04-20 | null | null | N | LENVATINIB | 101429574 |
| 20219131 | 20083513 | 1.45 | 86.8 | Palliative (P) | null | 2017-11-25 | null | null | N | CISPLATIN + ETOPOSIDE | 101377700 |
| 20219132 | 20083514 | 1.76 | 51 | Palliative (P) | 2019-07-24 | 2019-07-24 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 100529340 |
| 20219136 | 20083515 | null | null | null | null | 2019-02-04 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101685646 |
| 20219138 | 20083516 | 1.58 | 90 | null | 2017-04-28 | 2017-05-08 | CAPECITABINE + MITOMYCIN + RT | N | N | CAPECITABINE + MITOMYCIN + RT | 101839366 |
| 20219142 | 20083517 | null | null | null | 2017-10-27 | 2017-10-27 | null | null | null | CISPLATIN + ETOPOSIDE | 100437881 |
| 20219151 | 20083518 | 1.61 | 67.5 | Neo-adjuvant (N) | 2021-04-24 | 2021-05-12 | ECarboX | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100620499 |
| 20219154 | 20083520 | 1.6 | 63 | Neo-adjuvant (N) | 2017-11-23 | 2017-12-09 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + MITOMYCIN + RT | 100150504 |
| 20219157 | 20083521 | null | null | null | 2018-11-15 | 2018-12-13 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100790947 |
| 20219163 | 20083524 | null | null | null | 2019-11-07 | 2019-11-12 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101715870 |
| 20219166 | 20083525 | 1.67 | 62.5 | Palliative (P) | null | 2016-05-17 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101018147 |
| 20219167 | 20083526 | 1.72 | 94 | Palliative (P) | 2018-01-13 | 2018-01-19 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101174453 |
| 20219169 | 20083528 | null | null | null | 2019-07-03 | 2019-07-03 | null | null | null | CISPLATIN + ETOPOSIDE | 101499293 |
| 20219188 | 20083530 | null | null | null | null | 2016-10-22 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101386845 |
| 20219189 | 20083531 | null | null | null | 2017-07-24 | 2017-07-24 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 100410548 |
| 20219191 | 20083532 | null | 79 | null | 2019-04-16 | 2019-05-03 | null | null | null | CISPLATIN + ETOPOSIDE | 100164717 |
| 20219202 | 20083533 | null | null | null | 2016-06-13 | 2016-06-16 | Capecitabine (21 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 100987747 |